Connect with us
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.


Poxel and Sumitomo Dainippon Pharma Announce Positive Topline Phase 3 Results from TIMES 2 Trial of Imeglimin for the Treatment of Type 2 Diabetes in Japan and Successful Completion of the Pivotal TIMES Clinical Development Program


POXEL SA (Euronext “ POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), and Sumitomo Dainippon Pharma Co., Ltd (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura; Securities Code: 4506, First Section of TSE), today announced positive topline results from TIMES 2, a Phase 3 trial evaluating Imeglimin in combination with approved hypoglycemic therapies, and as a monotherapy, for the treatment of type 2 diabetes in Japan. These results mark the successful conclusion of the Phase 3 program in Japan, referred to as TIMES (Trials of IMeglimin for Efficacy and Safety), which included three pivotal trials to evaluate Imeglimins efficacy and safety in over 1,100 patients.

Type 2 diabetes is a progressive disease and involves the need for additional agents over time. Successful management of type 2 diabetes patients who are no longer controlled by one therapy will progress to combination therapy using agents with complementary mechanisms of action, said Prof. Kohei Kaku, MD, PhD, Department of Internal Medicine, Kawasaki Medical School, Okayama, Japan. In the Phase 3 TIMES 2 trial, Imeglimin was observed to demonstrate added efficacy benefits as add-on therapy to a DPP-4 inhibitor as well as other standard of care agents with different mechanisms, including metformin. The added efficacy benefits observed for Imeglimin in combination with other agents in the TIMES 2 trial combined with its favorable safety and tolerability profile, highlight Imeglimins potential as an innovative new treatment option to complement other existing hypoglycemic therapies.

The TIMES 2 trial further strengthens Imeglimins differentiated profile showcasing that its dual mechanism of action of increasing insulin secretion in response to glucose and improving insulin sensitivity was observed to show added efficacy benefits, especially with agents that have complementary mechanisms of action. In the 52-week, open-label, parallel-group trial, which evaluated the long-term safety and efficacy of Imeglimin in 714 Japanese patients with type 2 diabetes, 1,000 mg of Imeglimin was orally administrated twice daily in combination with existing hypoglycemic agents, including a DPP-4 inhibitor, a thiazolidine, an alpha-glucosidase inhibitor, a glinide, a biguanide, a SGLT-2 inhibitor, a sulphonylurea, and an injectable GLP1 receptor agonist or as monotherapy. The TIMES 2 trial, which was open-label and not placebo-controlled, was observed to show a glycated hemoglobin A1c (HbA1c) decrease from baseline at the end of the 52-week treatment (LS mean) period of:

  • -0.92% versus baseline with Imeglimin as an add on to a DDP-4 inhibitor
  • -0.88% versus baseline with Imeglimin as an add on to a thiazolidine
  • -0.85% versus baseline with Imeglimin as an add on to an alpha-glucosidase inhibitor
  • -0.70% versus baseline with Imeglimin as an add on to a glinide
  • -0.67% versus baseline with Imeglimin as an add on to a biguanide
  • -0.57% versus baseline with Imeglimin as an add on to a SGLT2 inhibitor
  • -0.56% versus baseline with Imeglimin as an add on to a sulphonylurea
  • -0.12% versus baseline with Imeglimin as an add on to a GLP1 receptor agonist
  • -0.46% versus baseline with Imeglimin as monotherapy

In addition, the TIMES 2 trial met another important efficacy endpoint and was observed to show a decrease in fasting plasma glucose (FPG) that was consistent with the reduction in HbA1c, except in the GLP1 group, which showed a stronger reduction in FPG when compared to the observed decrease in HbA1c.

In addition, the HbA1c and FPG decrease for Imeglimin as monotherapy were similar to previous studies in this population when measured from baseline (not placebo controlled), such as the Phase 2b trial in Japan.

In this trial, Imeglimin demonstrated a favorable safety and tolerability profile that was observed across all arms of the study. In addition, the adverse event profile was consistent with what was observed in the TIMES 1 monotherapy trial, the TIMES 3 trial in combination with insulin and prior clinical studies of Imeglimin.

“The TIMES 2 results represent a significant milestone for Imeglimin, with the completion of our robust Phase 3 program in Japan. Across all three pivotal TIMES trials, Imeglimin was observed to demonstrate the ability to safely and significantly reduce HbA1c, as a monotherapy, in combination with insulin and now in combination with other existing therapies,” said Thomas Kuhn, CEO of Poxel. Taken together, these results feature Imeglimins potential to treat type 2 diabetes at multiple stages of the disease. We are working very closely with our partner Sumitomo Dainippon Pharma in activities to complete and submit the Japanese New Drug Application in 20203, and to deliver this promising drug candidate to patients in 20213.

The TIMES program is a joint development effort between Poxel and Sumitomo Dainippon Pharma. The companies entered into a strategic partnership in October 2017 for the development and commercialization of Imeglimin in Japan, China, South Korea, Taiwan and nine other Southeast and East Asian countries.4

These positive results reinforce our observations from the TIMES 1 and TIMES 3 studies, and continue to demonstrate the efficacy benefits of Imeglimin, especially in combination with other approved therapies that have complementary mechanisms of action, said Nobuhiko Tamura, Member, Board of Directors, Senior Executive Officer; Drug Development Division of Sumitomo Dainippon Pharma. We believe that Imeglimin has the potential with its differentiated dual mechanism of action and favorable safety and tolerability profile to be an important addition to our existing diabetes franchise and could specifically complement our DDP-4 inhibitor and biguanide. We are committed to delivering new therapeutic options to help patients manage their disease.

Poxel anticipates submitting the full data results from the Phase 3 TIMES 2 trial for presentation at a scientific meeting 2020.

Conference Call Information: Poxel will host a conference call to discuss the results later today. To access the information please click this link or refer to Poxels website.

About the TIMES Program TIMES (Trials of Imeglimin for Efficacy and Safety), the Phase 3 program for Imeglimin for the treatment of type 2 diabetes in Japan, consists of three pivotal trials involving over 1,100 patients. The TIMES program includes the following three trials performed using the dose of 1,000 mg twice daily:

TIMES 1: A Phase 3, 24-week, double-blind, placebo-controlled, randomized, monotherapy trial that assessed the efficacy, safety and tolerability of Imeglimin in Japanese patients with type 2 diabetes, using the change in HbA1c as the primary endpoint. Secondary endpoints of the trial included fasting plasma glucose, other standard glycemic and non-glycemic parameters. The TIMES 1 trial met its primary and secondary endpoints and the topline results were reported on April 9, 2019.

TIMES 2: A Phase 3, 52-week, open-label, parallel-group trial that assessed the long-term safety and efficacy of Imeglimin in Japanese patients with type 2 diabetes. In this trial, Imeglimin was administrated orally as combination therapy with existing hypoglycemic agents, including a DPP-4 inhibitor, a SGLT2 inhibitor, a biguanide, a sulphonylurea, a glinide, an alpha-glucosidase inhibitor, a thiazolidine and a GLP1 receptor agonist or as monotherapy.

TIMES 3: A Phase 3, 16-week, double-blind, placebo-controlled, randomized trial with a 36-week open-label extension period that evaluated the efficacy and safety of Imeglimin in combination with insulin in Japanese patients with type 2 diabetes and inadequate glycemic control on insulin therapy. The TIMES 3 16-week portion of the trial met its primary endpoint and the topline results were reported on June 25, 2019. The TIMES 3 36-week open-label extension period met its primary objective and the topline results were reported on November 26, 2019.

About Imeglimin

Imeglimin is a new chemical substance classified as a tetrahydrotriazine compound, and the first clinical candidate in a chemical class. Imeglimin has a unique mechanism of action (MOA) that targets mitochondrial bioenergetics. Imeglimin acts on all three key organs which play an important role in the treatment of type 2 diabetes: the pancreas, muscles, and the liver, and it has demonstrated glucose lowering benefits by increasing insulin secretion in response to glucose, improving insulin sensitivity and suppressing gluconeogenesis. This MOA has the potential to prevent endothelial and diastolic dysfunction, which can provide protective effects on micro- and macro-vascular defects induced by diabetes. It also has the potential for protective effect on beta-cell survival and function. This unique MOA offers the potential opportunity for Imeglimin to be a candidate for the treatment of type 2 diabetes in almost all stages of the current anti-diabetic treatment paradigm, including monotherapy or as an add-on to other glucose lowering therapies.

About Poxel SA Poxel is a dynamic biopharmaceutical company that uses its extensive expertise in developing innovative drugs for metabolic diseases, with a focus on type 2 diabetes and non-alcoholic steatohepatitis (NASH). In its mid-to-late stage pipeline, the Company is currently advancing three drug candidates as well as earlier-stage opportunities. Imeglimin, Poxels first-in-class lead product, targets mitochondrial dysfunction. Together, with its partner Sumitomo Dainippon Pharma, Poxel is conducting the Phase 3 Trials of IMeglimin for Efficacy and Safety (TIMES) program for the treatment of type 2 diabetes in Japan. Poxel also established a partnership with Roivant Sciences for Imeglimins development and commercialization in countries outside of the partnership with Sumitomo Dainippon Pharma, including the U.S. and Europe. PXL770, a first-in-class direct adenosine monophosphate-activated protein kinase (AMPK) activator, is in a Phase 2a proof-of-concept program for the treatment of NASH. PXL770 could also have the potential to treat additional metabolic diseases. PXL065 (deuterium-stabilized R-pioglitazone), a mitochondrial pyruvate carrier (MPC) inhibitor, is advancing into a Phase 2 clinical trial for the treatment of NASH. Poxel also has additional earlier-stage programs targeting metabolic, specialty and rare diseases. The Company intends to generate further growth through strategic partnerships and pipeline development. Listed on Euronext Paris, Poxel is headquartered in Lyon, France, and has subsidiaries in Boston, MA, and Tokyo, Japan. For more information, please visit:

About Sumitomo Dainippon Pharma¨ Sumitomo Dainippon Pharma defines its corporate mission as “to broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide”. By pouring all our efforts into the research and development of new drugs, we aim to provide innovative and effective pharmaceutical solutions to people not only in Japan but also around the world in order to realize our corporate mission. Sumitomo Dainippon Pharma aims to create innovative pharmaceutical products in the Psychiatry & Neurology area, the Oncology area and Regenerative Medicine & Cell Therapy, which have been designated as the focus research areas. Sumitomo Dainippon Pharma has also positioned Psychiatry & Neurology, Diabetes and Specialty as our focus marketing areas in Japan. For more detail, please visit our website. (URL:

All statements other than statements of historical fact included in this press release about future events are subject to (i) change without notice and (ii) factors beyond the Companys control. These statements may include, without limitation, any statements preceded by, followed by or including words such as target, believe, expect, aim, intend, may, anticipate, estimate, plan, project, will, can have, likely, should, would, could and other words and terms of similar meaning or the negative thereof. Forward-looking statements are subject to inherent risks and uncertainties beyond the Companys control that could cause the Companys actual results or performance to be materially different from the expected results or performance expressed or implied by such forward-looking statements.


1 IQVIA data FY2016 and NDB data FY2016 2 Year noted is Fiscal Year from April to March, which is Sumitomo Dainippon Pharmas Fiscal Year. 3 Year noted is Fiscal Year from April to March, which is Sumitomo Dainippon Pharmas Fiscal Year. 4 including Indonesia, Vietnam, Thailand, Malaysia, The Philippines, Singapore, Republic of the Union of Myanmar, Kingdom of Cambodia and Lao People’s Democratic Republic.

Poxel SA

Jonae R. Barnes

Senior Vice President, Investor Relations and Public Relations

[email protected]

+1 617 818 2985

Aurélie Bozza

Investor Relations & Communication Director

[email protected]

+33 6 99 81 08 36

Investor relations / Media – EU/US

Trophic Communications

Stephanie May or Joanne Tudorica

[email protected] or [email protected]

+49 89 238 877 34 or +49 171 185 56 82

Investor relations / Media – France


Alexia Faure / Arthur Rouillé

[email protected]

+33 1 44 71 94 94

Public relations / Media – Japan/Asia

Cosmo PR

Bertram Oba

[email protected]

International Account Manager

Tel: 03-5561-2915, Mobile: 080-7931-1844

Sumitomo Dainippon Pharma Co., Ltd.

Corporate Communications

Tel: +81-6-6203-1407 (Osaka); +81-3-5159-3300 (Tokyo)


CIC-Zero Carbon Park Presents: “Art in Construction” Exhibition with 3D Virtual Tour


  • The Art of Innovative Construction
  • Explore sustainable green living with Hong Kong artists

HONG KONG, CHINA – Media OutReach – 21 September 2020 – Construction Industry Council — Zero Carbon Park (CIC-ZCP) proudly presents: “Art in Construction”, an exhibition that gathers local artists to explore and showcase the connection and creativity between construction and art through various forms including sculptures, installations, paintings, photography, and workshops. Starting from today, “Art in Construction” is held at the CIC-ZCP in Kowloon Bay and supported by a free online virtual exhibition and a guided tour video. By incorporating 360-degree camera technology, the exhibition allows everyone to experience the creativity of construction, engage with art, and sample what it’s like to live a greener lifestyle.

The Art of Innovative Construction

The evolution of construction throughout history demonstrates mankind’s creativity and commitment to sustainability. From building houses and cities with wood and stone to today’s use of innovative technology and sustainable methods to establish communities living in harmony with nature. CIC-ZCP is pleased to present “Art in Construction”, an exhibition and a series of activities that showcases the synergy between construction and green living. Like art, the imagination and creativity of construction are both impressive and breath-taking.

Mr. CHONG Kin-lit, Paul, Chairman of CIC-ZCP, remarked in the exhibition’s promotional video: “Climate change is one of the biggest challenges confronting mankind. CIC-ZCP is a pioneering and inspiring project serving as a knowledge-sharing platform for industry practitioners in low carbon building design and technologies. By organising various types of promotional activities, it is our mission to increase public awareness of low carbon living. Recently, CIC-ZCP has been completely renovated with several innovative green initiatives. Allied with the art pieces, we hope to bring an exciting facelift.”

‘Construction’ is more than an industry. The word itself evokes a sense of mankind’s inventive spirit in order to keep up with modern times. Located at CIC-ZCP, ‘Art in Construction’ highlights the creativity of construction and the part technology plays in turning high-quality green homes into a reality. This gives the public a better insight into the philosophies that go into sustainable design, and better appreciation for the creativity and vision behind them”. Mr CHONG continued.


Construction and art never stops, even during the pandemic. “Art in Construction” is also available for free as a virtual tour at By browsing the virtual exhibition, visitors can get a 360-degree view of the exhibits. In addition, a guided tour video will launch on 25 September, during which the curator and artists will take the public into the world of art and construction to understand the stories behind CIC-ZCP and the exhibits.

The four themes of “Art in Construction”:


Art and Construction: A Crossover Experience

While high-rises and parks are designed meticulously by architects, building desirable homes requires concerted effort from the community. With painting, toys and building blocks, Artist LAM Tung-pang constructs his ideal city–complete with hills, people and high-rises–in the installation, Things Happened on the Island. He invites visitors to rearrange components to build the city together with him, a process evocative of the collaboration and rapport behind green communities and innovative technology in urban development.

Fusing Oriental and Natural Charm

Sustainable development and green living seem to be relatively modern concepts. In fact, since ancient times, the Chinese have long believed in the importance of the symbiosis between man and nature. Referencing natural elements like water and wind, veteran Hong Kong Sculptor LEE Chin-fai, Danny has created Urban Waterscape, a group of outdoor sculptures that double as benches for public use. Artist LAU Hok-shing, Hanison has combined Penjing, or miniature landscapes in Sitting Table — Hong Kong, with Chinese Ta, a type of platform seating, to create a space for outdoor recreation where people can meet and relax. With artistic craftsmanship, Lee and Lau demonstrate mankind’s philosophy of co-existing with all things in nature, whilst also preserving tradition and illustrating the possibilities of green living.

Concerns about Environmental Issues

This year, temperatures in the Arctic Circle reached a new peak of 20 degrees Celsius, while carbon emissions in various regions are still on the rise. As people pursue their ideal homes, global warming and the greenhouse effect remain acute issues that need to be addressed. Many artists around the world are emphasising the importance of environmental protection with their art. Photographer LAU Chi-chung has been portraying the countryside for many years. In Landscaped Artifacts, he has created a beautiful composition of woods and village houses that convey the tension between human expansion and the forces of nature. Painter YUEN Chun-tai, Ivy has spent half a year walking through multiple hiking trails alongside reservoirs in Hong Kong. A series of drawings named Forestry illustrates the rise and fall of Hong Kong’s horsetail pine population and how it parallels the city’s urbanisation, as well as increase in plantation projects and the threat of pests.

Sculptor MOK Yat-san often depicts polar bears, one of the victims of global warming, in various forms. The name of the art piece Beware of the P Bear is a humorous but thought-provoking reminder to bear in mind the severity of climate change. Another one of MOK’s exhibits, Lovingkindness, resembles traditional Penjing (the ancient Chinese art of depicting trees and landscape in miniature) by condensing architecture and juxtaposing the mini-scenery with a polar bear. Visitors can then get a bird’s eye view of the landscape from above, shedding their physical limitations, and exploring the organic relationships between landscape, trees and rocks in miniature form. The intention of using Penjing is also so that visitors can visualise themselves taking a leisurely stroll through the scenery.

Practise Green Living

Humans are like builders of life. Similarly, artists are mindful of sustainability in their everyday lives and practices too. In Modern Landscape, Artist WONG Chun-yam, Leo upcycles rocks and cement fragments collected from construction sites to form sculptures, recreating the stories once told by the structures themselves. Meanwhile, Artist Duo MUDWORK invites visitors to practise green living through their artistic creation, Tree Call which makes use of wood fragments to create small DIY bird whistles. Farmside Art Research Lab (Part-farmer, part-artist Monti LAI and cross-disciplinary artist Meiki LEE) is inviting the public to participate in the Roving with Bamboo Ink — Nature Is Art workshop. The workshop is designed to take place in the familiarity of home and to initiate one’s connection with nature through breathing exercises, creative poetry, and drawings created by ink pressed from vegetable leaves.

Photos Download

“Art in Construction” Programmes

Date                                18 September (Friday) to 17 October 2020 (Saturday)

Location                        Construction Industry Council — Zero Carbon Park

                                        8 Sheung Yuet Road, Kowloon Bay, Hong Kong

Time                               09:00 — 20:00 (Indoor) ; 07:00 — 20:00 (Outdoor)

Online Exhibition

Guided Tour Video    Launch on 25 September 2020 (Friday)

Workshop Video         Roving with Bamboo Ink — Nature Is Art

                                        Launch on 26 September 2020 (Saturday)



Art in Construction” Exhibits and Workshop Highlight


Things Happened on the Island

Acrylics, charcoal, pencil, scale model and wooden toys on plywood

LAM combines painting with a three-dimensional model and invites visitors to join the creative process in a humorous and interesting way. Visitors can use the toy blocks to create their own ideal cities as an extension to the scene.

LEE Chin-fai, Danny:

Urban Waterscape

Stainless steel, iron

Derived from the concept of three-dimensional papercutting, the installation tries to capture the movement of flowing water by simulating the silhouette of waves and ripples, forming an interesting and welcoming urban waterscape.

LAU Hok-shing, Hanison:

Sitting Table — Hong Kong

Wood, daily objects

An art piece that doubles as a bench that people can sit or lay on. By using regularly available materials and discarded items found on the street, elements of a garden are combined to create mountains and rivers in order to demonstrate enjoyment in life is not merely based on materialism.

LAU Chi-chung:

Landscaped Artifacts


Seasonal changes make the process of creation a volatile one. By capturing the ruins found in nature, LAU’s work bears witness to lived lives and passed time. Mankind made his mark on the land he walked, but Mother Nature is now taking her turn to give it a makeover. Though unable to turn back the clock, she has transformed the land into an environmental sculpture.

YUEN Chun-tai, Ivy:



After reading through century-old reports from the Hong Kong Botanical and Afforestation Department, YUEN walked along reservoirs small and large, trying to find the remaining horsetail pines (Pinus Massoniana) in Hong Kong — hundreds of thousands of which had been planted (now gone) in order to present the tree-planting history of previous generations.


MOK Yat-sun:

Be Aware of the P Bear

Painted fibreglass

It seems surreal that a polar bear is lying on an open space in the heart of an urban metropolis. Although we are many miles from the Arctic, as a member of the “Global Village”, how can we turn a blind eye to the threat of global warming? The surreal artwork reminds us of the need to strike a balance between urban development and nature conservation.

MOK Yat-sun:


Stainless steel & gold sheets

MOK’s work resembles the design of Chinese Penjing with a view to portraying an elegant world within a microscopic setting. Visitors can get a bird’s eye view of the landscape and explore the organic relationships between landscape, trees and rocks amongst the miniatures. A close look further helps unlock the imagination, taking the mind on a leisurely stroll of the garden.

WONG Chun-yam, Leo:

Modern Landscape

Mixed media

WONG upcycles rocks and cement fragments collected from construction sites into architectural sculptures, recreating the stories once told by the structures themselves.


Tree Call


The trees may remember the birds singing and the birds may remember the trees. However, the birds can no longer be heard. Through processing local wood and turning it into bird whistles, the tune of nature can be heard again.


Farm Side Art Research Lab: Roving with Bamboo Ink — Nature Is Art

The Bamboo Ink — Nature Is Art workshop is designed to take place in the familiarity of home and to initiate one’s connection with nature through breathing exercises, creative poetry, and drawings created by ink pressed from vegetable leaves.

About the Construction Industry Council

The Construction Industry Council (CIC) was formed in 2007 under the Construction Industry Council Ordinance (Cap. 587). The CIC consists of a chairman and 24 members representing various sectors of the industry including employers, professionals, academics, contractors, workers, independent persons and Government officials.

The main functions of the CIC are to forge consensus on long-term strategic issues, convey the industry’s needs and aspirations to the Government, provide professional training and registration services, and serve as a communication channel between the Government and the construction industry. Please visit for further details.

About CIC-Zero Carbon Park

Established in June 2012 and located in 8 Sheung Yuet Road, Kowloon Bay, CIC-Zero Carbon Park (CIC-ZCP) is the first zero carbon building in Hong Kong developed by the Construction Industry Council (CIC) in collaboration with the Government. CIC-ZCP is an exhibition and education centre for advanced ecological building design, as well as an information centre for low/zero carbon building technologies, promoting low carbon living and the development of smart city in Hong Kong.


Facebook [View Image]


Instagram [View Image]


Continue Reading


STC International lights up the rural area in ASEAN


TAIPEI, TAIWAN – Media OutReach – 21 September 2020 – STC International, a Taiwanese company specialized in solar energy system integration, under the assistance of GTPO (Green Trade Project Office) and ITRI, successfully built its presence from the ground up in the ASEAN market. From Cambodia’s rural area to Malaysia, from NGOs to retail restaurants, STC’s solutions are being adopted in ASEAN nations thanks to its leading technology and services. STC is a perfect example of a SME bringing its flexibilities and niche focus into full play.

 Green Energy Solution in Cambodia by STC


It all started in 2017 when STC International took part in ITRI’s trade promotion delegation and visited the rural village in Cambodia, the aim of the trip was to build solar power system for a local NGO. This NGO regularly invites doctors to the village to provide volunteer medical services. Electronic devices and cooling equipment for medical purpose require basic power supply, but local power supply is very unstable and power outages are frequent.’


After ITRI introduced STC International to the Cambodian NGO, STC International soon put together a comprehensive system including illumination, fans, solar panels, energy storage and cooling devices for this customer. “As soon as the system entered service, the NGO is the only place that is brightly lit after sunset with a few miles around the neighborhood. Local businesses and stores were amazed and came to us for solar system infrastructure. Coffee shops, Chinese-language cram schools and other business operators all become his customers,” said Mr. Polun Chen, General Manager of STC International.


Mr. Chen also said that before STC came, local community used to have a false impression that solar system was expensive and dangerous. With the NGO became a model site, people quickly accepted solar energy with confidence.


Until now, STC’s energy solutions have been adopted in farming irrigation systems, retail and catering, and small factories. Take irrigation for example, diesel generators were widely used by farmers for groundwater mining, which created rumbling noises and air pollution. Also, replenishing diesel fuel was inconvenient. All these problems are solved after solar panel and storage was installed.

Malaysia is another market where STC International has solid gains. Polun Chen indicated that Malaysia is totally different in market environment from Cambodia. In Cambodia, power outages are common and power grids still cannot reach a lot of area. In contrast, Malaysia has sufficient power supply and the electricity cost is low. STC International obviously needs to adopt different strategy in Malaysia. With the help of the ITRI, STC International established relations with Malaysia’s official energy-saving certification agency GreenTech, which has a goal to introduce green energy to the country. Until now, STC International had designed comprehensive energy storage system in Malaysia.


STC International is focusing on small-scale pilot projects. Similar projects are abundant out there for Taiwanese companies to win.

Continue Reading


Scenario-based healthcare products prevailing in post-pandemic era, Qingsong Health Group Insurance rises as new hit in Chinese digital insurance industry: Hurun Report


SHANGHAI, Sept. 21, 2020 /PRNewswire/ — Hurun Report, a leading provider of high-quality lists and research, released Hurun China Digital Insurance Agencies 2020 on 16 September, 2020. The report, the first of its kind by Hurun Report, lists the 10 highest-rated digital insurance agencies in China based on their business performance and innovation abilities in the past two years. 

Digital insurance refers to a business model supported by the internet, mobile communication networks and other technologies, which sees the insurer and the insured signing contracts and providing services though insurer-owned online platforms or third-party purchasing platforms.

With a long industry chain and diversified products, the insurance sector is highly integrated with other industries. Hence, various platform business models have emerged in the digital insurance sector.

It is worth noting that the list in this report focuses on internet and tech enterprises that hold stake in, invest in or set up online insurance agencies with individual customers and insurance agents as targets. Insurance agencies targeting corporate clients are excluded from the list. In addition, research in this report only covered private businesses in the Chinese mainland. 

The post-pandemic era has seen health becoming one of the hottest topics and diversified insurance products, said Rupert Hoogewerf, the chairman and chief researcher of Hurun Report. Quoting statistics from Insurance Association of China, Hoogewerf said Chinese insurers’ premium income increased by 6.5 percent year on year to 2.7 trillion yuan in the first half of the year.

Insurance agencies have played a crucial part in insurance purchases, whose premium income has accounted for over 80% of the total premium income for the past consecutive years, Hoogewerf noted, adding that the practice of independent service providing and marketing has shaped the insurance sector, and, at present, near 70% of China’s 700 national insurance agencies are eligible to market online.

Digital insurance in China has enjoyed leap-forward development in the past years, Hoogewerf said. He further explained that, besides internet giants Baidu, Alibaba, Tencent and, Ctrip, Didi, Meituan and other platforms have rolled out insurance services. Relying on massive active users and taking advantages of big data and cloud computing technologies, those companies have designed insurance products in accordance with the consumption scenarios of their original platforms, including entertainment, shopping, travelling and mutual health aid, to meet the insurance needs of different customer groups, said Hoogewerf. For instance, Hoogewerf added, Ant Insurance provides shipping insurance for online shopping and Ctrip offers insurance for flight accidents and delay.

In digital insurance business, there are other companies that worth gaining people’s attention, such as scenario-based health insurance marketing agencies represented by Qingsong Health Group’s insurance platform, and China’s earliest online platforms that obtained online insurance brokerage licenses represented by Huize Insurance, said Hoogewerf.

As insurtech embraces a new development era in both China and the global market, multiple business players have been competing for the position of industry leaders, Hoogewerf noted. He said the prospects of Chinese digital insurance agencies are promising, given the trend of independent service providing and marketing in insurance industry as well as the rapid development of internet technology.

Top 10 of Hurun China Digital Insurance Agencies 2020


Affiliated enterprise

Headquarters location



Tencent Holdings Ltd



Ant Insurance

ANT Group Co., Ltd



Qingsong Health Group

Qingsongchou Network Technology Co. Ltd



Huize Holding Ltd




Beijing Zongqing Xiangqian Science and Technology Co., Ltd. 



Jingdong Insurance

Beijing Jingdong Financial Technology Holding Co., Ltd



Suning Insurance

Suning Financial Services (Shanghai) Co., Ltd



Ctrip Insurance Services

Shanghai Ctrip Business Co., Ltd



WeiEase Tech App

Hangzhou WeiEase Tech Co., Ltd.



Duxiaoman Insurance

Beijing Duxiaoman Technology Co., Ltd.


Source: Hurun Report

Brief introduction of examples of agencies on the List

WeSure, an example of digital insurance agencies affiliated to the internet giants

In 2017, Tencent officially launched its online insurance subsidiary WeSure in its WeChat Pay service, aiming to connect potential insurance clients with different insurance scenarios by capitalizing on the high engagement rate of WeChat and other social media networks under Tencent. WeSure enables consumers to buy various insurance products, inquire and settle claims online via WeChat and QQ. So far, WeSure has established cooperative relations with around 20 insurers including Taikang Online and PICC. In 2018, the platform introduced Insurance Hongbao, a stimulus of certain amount of money that encouraged WeSure users enrolling their WeChat contacts as new users and therefore targeted potential clients. In July 2020, WeSure, along with media and a dozen of insurers, launched China’s first insurance festival which saw the participation of 148 million users. WeSure data showed its total compensation in 2019 exceeded 330 million yuan, seven times of that of 2018.

Insurance platform of Qingsong Health Group, an example of digital insurance agencies affiliated to online crowdfunding platforms

Established as a crowdfunding platform for serious illness treatment, Qingsong Health Group has helped cultivating users’ awareness to insurance. It then started its insurance agency catering to the needs of its user group and insurance clients. Based on users of Qingsong Health Group, the insurance platform interacted with the group’s other subsidiaries, such as the crowdfunding and public benefit platforms. After its upgradation in 2020, the insurance platform, collaborating with insurers CPIC and Zhongan, launched a marketing campaign targeting users in their 20s and 30s. By measures of allowing using daily steps to deduct premiums and encouraging payment by instalments, the campaign had made it easier for young users buying insurance.  

Huize Insurance, an example of professional digital insurance agencies

Founded in 2006, was among the earliest few platforms in the country obtaining online insurance brokerage licenses. Its establishment marked the birth of China’s first Internet insurance "supermarket" that integrated insurance purchase and product comparison. Being an early bird and hence benefiting from advantages in attracting users and partners as well as technological supporting, has reshaped the insurance sector through offering clients one-stop integrated insurance solutions. In regard of brand marketing, the platform cooperates with 17,000 media marketing entities, covering WeChat, Zhihu, Sina Weibo and other leading social media communities. The marketing contents targeting individual users focuses on insurance knowledge introduction, product comparison and evaluation. The comprehensive marketing strategies have brought significant and constant attention to the platform. Through online customer support and call center service, achieves efficient communication with users and conducts purchases. Insurance premiums of Huize Insurance in 2019 exceeded 2 billion yuan, an year-on-year increase of 110%. In February 2020, Huize Holding Limited successfully listed and commenced trading on Nasdaq Global Market.

About list compilation: This list was compiled via qualitative and quantitative comprehensive research methods. Firstly, basing on recommendations by industry experts and published information, Hurun Report selected nearly 150 corporates with digital insurance operations and conducted a preliminarily screening (including confirming basic information such as headquarters locations, founding date, insurance brokerage qualification, etc.). Then, researchers made a thorough study on 40 enterprises with satisfying performance. Through in-depth analysis of overall information of the targeted companies (including profile, shareholder structure, public relations, partnership relations, enterprise value and financing information, number of users, reputation, marketing strategy, etc.), Hurun Report rated the companies by 12 indicators of 4 dimensions with the quantitative method. The top 10 platforms were selected based on comprehensive ratings.   

Continue Reading
gbafNews28 gbafNews28
News42 mins ago

STC International lights up the rural area in ASEAN

TAIPEI, TAIWAN – Media OutReach – 21 September 2020 – STC International, a Taiwanese company specialized in solar energy system...

gbafNews28 gbafNews28
News42 mins ago

CIC-Zero Carbon Park Presents: “Art in Construction” Exhibition with 3D Virtual Tour

The Art of Innovative Construction Explore sustainable green living with Hong Kong artists HONG KONG, CHINA – Media OutReach – 21 September...

gbafNews28 gbafNews28
News49 mins ago

Scenario-based healthcare products prevailing in post-pandemic era, Qingsong Health Group Insurance rises as new hit in Chinese digital insurance industry: Hurun Report

SHANGHAI, Sept. 21, 2020 /PRNewswire/ — Hurun Report, a leading provider of high-quality lists and research, released Hurun China Digital...

gbafNews28 gbafNews28
News2 hours ago

Echoworx Recognized in 2020 Gartner Market Guide for Email Security

Echoworx is proud to be recognized in the Email Data Protection Specialists category in Gartner Market Guide for Email Security...

gbafNews28 gbafNews28
News2 hours ago

Sagemcom AMI Solution, a Key Driver in the Swedish Energy Transition to a Sustainable Future

In September, ELLEVIO will continue to improve the Swedish electricity system by being one the first Nordic DSO to start...

gbafNews28 gbafNews28
News3 hours ago

Market Failure? kENUP and YUVEDO High-Level Online Event Kick-starts Call for Projects Tackling the Growing Threat of Parkinson’s and Other Neurodegenerative Diseases.

On Friday, 18 September 2020, YUVEDO Foundation and kENUP Foundation held a high-level online conference to kick-start an open public...

gbafNews28 gbafNews28
News3 hours ago

Ping An Launches its First UCITS Umbrella Fund

Fund offers global investors diversified investment opportunities across China equity and fixed income markets HONG KONG, SHANGHAI and LUXEMBOURG, Sept....

gbafNews28 gbafNews28
News3 hours ago

AIA Singapore creates up to 500 new career opportunities for fresh graduates and mid-career switchers impacted by COVID-19

AIA Financial Career Scheme 2020 will provide eligible candidates with comprehensive financial services training as well as vital financial support...

gbafNews28 gbafNews28
News3 hours ago

Atos and RingCentral Launch Unify Office in France

Atos SE (CAC40: ATO), a global leader in digital transformation and RingCentral, Inc. (NYSE: RNG), a leading provider of global...

gbafNews28 gbafNews28
News3 hours ago

Vela Named Best Low-Latency Data/Technology Provider

Vela, a leading independent provider of data and execution technology for global multi-asset electronic trading, has won the Inside Market...